Wolverine Asset Management LLC Increases Stake in Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC)

Wolverine Asset Management LLC raised its holdings in shares of Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) by 5.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 183,110 shares of the company’s stock after acquiring an additional 10,000 shares during the period. Wolverine Asset Management LLC’s holdings in Bellevue Life Sciences Acquisition were worth $1,923,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Schechter Investment Advisors LLC boosted its position in shares of Bellevue Life Sciences Acquisition by 84.1% in the fourth quarter. Schechter Investment Advisors LLC now owns 211,227 shares of the company’s stock worth $2,218,000 after purchasing an additional 96,516 shares during the period. Wealthspring Capital LLC boosted its position in shares of Bellevue Life Sciences Acquisition by 335.7% in the fourth quarter. Wealthspring Capital LLC now owns 87,579 shares of the company’s stock worth $920,000 after purchasing an additional 67,479 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of Bellevue Life Sciences Acquisition by 82.8% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 220,723 shares of the company’s stock worth $2,296,000 after acquiring an additional 100,000 shares during the last quarter. Robinson Capital Management LLC bought a new position in shares of Bellevue Life Sciences Acquisition during the third quarter worth $438,000. Finally, Periscope Capital Inc. boosted its position in shares of Bellevue Life Sciences Acquisition by 2,175.8% during the third quarter. Periscope Capital Inc. now owns 615,652 shares of the company’s stock worth $6,403,000 after acquiring an additional 588,600 shares during the last quarter. 55.30% of the stock is owned by hedge funds and other institutional investors.

Bellevue Life Sciences Acquisition Stock Performance

Shares of NASDAQ:BLAC opened at $10.69 on Thursday. The firm has a fifty day moving average price of $10.66 and a 200 day moving average price of $10.55. Bellevue Life Sciences Acquisition Corp. has a fifty-two week low of $10.11 and a fifty-two week high of $11.16.

Bellevue Life Sciences Acquisition Company Profile

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.